312 results
Page 13 of 16
F-1
EX-10.50
pc6ihnnzi7
21 Jul 20
Registration statement (foreign)
8:17am
F-1
bb2ew12yf tk
21 Jul 20
Registration statement (foreign)
8:17am
F-1
EX-10.46
wh5wuoji1lx9d
21 Jul 20
Registration statement (foreign)
8:17am
F-1
EX-21.1
oobrd0 ljhetmvf
21 Jul 20
Registration statement (foreign)
8:17am
6-K
EX-99.1
je0bhko7e4
20 Jul 20
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
8:53am
6-K
EX-99.1
6oktfctsb13bdn szol6
20 Jul 20
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
6:42am
6-K
EX-99.1
q3ui5sp 66kdex5p
13 Jul 20
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
6:53am
6-K
EX-99.1
79c597n90hmj6p54kizb
1 Jul 20
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
10:01am
6-K
EX-99.2
j7kjxr of
1 Jul 20
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
10:01am
DRS
583wtcoz
15 Jun 20
Draft registration statement
12:00am
DRS
h9tcqat6vaq2shy
12 Jun 20
Draft registration statement
12:00am
6-K
EX-99.1
5xcfg10 czixe6eln8
11 Jun 20
Current report (foreign)
7:59am
6-K
EX-99.1
ihrjzfq
12 May 20
BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
5:25pm
6-K
EX-99.1
xew6e3
5 May 20
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
7:03am
6-K
EX-99.1
qbklr
29 Apr 20
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
7:03am
6-K
EX-99.1
uhduvn
22 Apr 20
JPT Launches Broad Spectrum of COVID-19 Peptide Tools for Immune Monitoring, Vaccine & Diagnostics Development
7:09am
6-K
EX-99.1
eg3xxgs3i20 5zbftv
9 Apr 20
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
8:24am
424B3
3u2 be6zs44hs
2 Apr 20
Prospectus supplement
4:25pm
F-4
l7rs mwtacy
1 Apr 20
Registration of securities (foreign)
12:00am
425
pc0vcpwdb2va7eo
31 Mar 20
Business combination disclosure
5:09pm